Publications by authors named "Jan Basile"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,560

Total Likes

118

Extended Reach

125,555

Social Features

50
C
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.
Stephen J Nicholls, Deepak L Bhatt, John B Buse, Stefano Del Prato, Steven E Kahn, A Michael Lincoff, Darren K McGuire, Michael A Nauck, Steven E Nissen, Naveed Sattar

Am Heart J· January 2024

Videos about Article: user user

2 1 47 2 11

View All Article and Social Media Activity
C
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.
Stephen J Nicholls, Imre Pavo, Deepak L Bhatt, John B Buse, Stefano Del Prato, Jan Basile

N Engl J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hickam's Dictum in Hypertension.
Gregory L Hundemer, Brian D M Blew, Ashish Gupta, Julie L V Shaw, Jason Wasserman, Jan N Basile

Hypertension· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
36-month durability of ultrasound renal denervation for hypertension resistant to combination therapy in RADIANCE-HTN TRIO.
Michael J Bloch, Ajay J Kirtane, Michel Azizi, Felix Mahfoud, Jan Basile

Hypertens Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Hypertension in Older Adults.
Brent M Egan, Holly J Mattix-Kramer, Jan N Basile, Susan E Sutherland

Curr Hypertens Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program.
Michel Azizi, Andrew S P Sharp, Naomi D L Fisher, Michael A Weber, Melvin D Lobo, Jan Basile

Circulation· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials.
Ajay J Kirtane, Andrew S P Sharp, Felix Mahfoud, Naomi D L Fisher, Roland E Schmieder, Jan Basile

JAMA Cardiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial.
Edward Franek, Prem Pais, Jan Basile, Claudia Nicolay, Sohini Raha

Cardiovasc Diabetol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.
Michel Azizi, Manish Saxena, Yale Wang, J Stephen Jenkins, Chandan Devireddy, Jan Basile

JAMA· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial.
Michel Azizi, Felix Mahfoud, Michael A Weber, Andrew S P Sharp, Roland E Schmieder, Jan Basile

JAMA Cardiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial.
Kelley R H Branch, Gilles R Dagenais, Alvaro Avezum, Jan Basile, Ignacio Conget

Eur J Heart Fail· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes.
Hertzel C Gerstein, Chinthanie Ramasundarahettige, Alvero Avezum, Jan Basile, Ignacio Conget

Cardiovasc Diabetol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study.
Manish Saxena, Roland E Schmieder, Ajay J Kirtane, Felix Mahfoud, Joost Daemen, Jan Basile

J Hum Hypertens· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
Tali Cukierman-Yaffe, Hertzel C Gerstein, Jan Basile, M Angelyn Bethel, Ernesto G Cardona-Muñoz

J Clin Endocrinol Metab· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.
Peter J Raubenheimer, William C Cushman, Alvaro Avezum, Jan Basile, Ignacio Conget

Diabetes Obes Metab· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial.
Anita Y M Kwan, Hertzel C Gerstein, Jan Basile, Denis Xavier, Juan M Maldonado

Diabetes Care· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial.
Felix Mahfoud, Michael J Bloch, Michel Azizi, Yale Wang, Roland E Schmieder, Jan Basile

EuroIntervention· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF.
David E Kandzari, Raymond R Townsend, George Bakris, Jan Basile, Michael J Bloch

Catheter Cardiovasc Interv· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial.
Harpreet S Bajaj, Hertzel C Gerstein, Purnima Rao-Melacini, Jan Basile, Helen Colhoun

Lancet Diabetes Endocrinol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Giulia Ferrannini, Hertzel Gerstein, Helen Martina Colhoun, Gilles R Dagenais, Rafael Diaz, Jan Neil Basile

Eur Heart J· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
Michel Azizi, Kintur Sanghvi, Manish Saxena, Philippe Gosse, John P Reilly, Jan Basile

Lancet· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How We Got Where We Are in Blood Pressure Targets.
Johann Herberth, Karim M Soliman, Tibor Fülöp, Jan N Basile

Curr Hypertens Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs.
Matthew R D'Costa, Sandra J Taler, Anna F Dominiczak, Rhian M Touyz, Robert M Carey, Jan N Basile

Hypertension· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation.
Michel Azizi, Joost Daemen, Melvin D Lobo, Felix Mahfoud, Andrew S P Sharp, Jan Basile

JACC Cardiovasc Interv· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis.
Gilles R Dagenais, Lars Rydén, Lawrence A Leiter, Mark Lakshmanan, Leanne Dyal, Jan Basile

Cardiovasc Diabetol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis